← Open Payments lookup

CHRISTOPHER SUPERCZYNSKI: Open Payments

NPI 1184621138 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,101 in 101 payments from 19 companies in 2025. Trend: 2023 $1,708 · 2024 $1,779 · 2025 $2,101

Food & beverage: $2,101
CompanyPaymentsAmount
PFIZER INC.18$358
ABBVIE INC.18$310
AstraZeneca Pharmaceuticals LP10$289
Abbott Laboratories9$178
GlaxoSmithKline, LLC.6$114
Novo Nordisk Inc4$104
Lundbeck LLC5$102
Sumitomo Pharma America, Inc.4$88
TOLMAR, INC.3$87
Exact Sciences Corporation5$83

Products named: ELIQUIS, FREESTYLE LIBRE 3, VRAYLAR, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA, REXULTI.

Industry payments across RI — which companies pay providers there.